-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ION-547 in Thrombosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ION-547 in Thrombosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.ION-547 in Thrombosis Drug Details:ION-547 is under development for the treatment of thrombosis. It...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ION-582 in Angelman Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ION-582 in Angelman Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.ION-582 in Angelman SyndromeDrug Details:ION-582 is under development for the treatment of Angelman...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ION-541 in Amyotrophic Lateral Sclerosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ION-541 in Amyotrophic Lateral Sclerosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ION-541 in Amyotrophic Lateral Sclerosis Drug Details: ION-541 is under development...
-
Track & Monitor
Batteries in automotive: Li-ion secondary battery
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the automotive industry’s Li-ion secondary battery segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based...
-
Analyst Opinions
NewBattery Manufacturing Construction Project Insights and Analytics (Q1 2024)
Battery Manufacturing Construction Projects Report Overview The total value of battery manufacturing construction projects is $484 billion in Q1 2024 at all stages from announcement to execution. Increased demand for energy storage and the shift towards electric vehicles (EV) are driving investments in battery projects. Economic growth and environmental awareness are creating the need and financial means to transition from Internal Combustion Engine (ICE) driven vehicles to EVs. Clean energy from wind and solar power plants and storage of power...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Povorcitinib Phosphate in Hidradenitis Suppurativa
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Povorcitinib Phosphate in Hidradenitis Suppurativa report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Povorcitinib Phosphate in Hidradenitis Suppurativa Drug Details: Povorcitinib (INCB-54707) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Avibactam + Aztreonam) in Ventilator Associated Pneumonia (VAP)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Avibactam + Aztreonam) in Ventilator Associated Pneumonia (VAP) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Avibactam + Aztreonam) in Ventilator Associated Pneumonia (VAP)...
-
Sector Analysis
Premature Labor (PL) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Premature Labor (PL) Marketed and Pipeline Drugs Report Overview Premature/preterm labor (PL) is labor occurring after 20 and before 37 weeks gestation. Premature deliveries cause more than half of long-term morbidity and 75% of perinatal mortality. Premature labor is diagnosed primarily by history and symptoms. Symptoms of preterm labor include regular contractions before term gestational age associated with cervical change, pelvic pressure, menstrual-like cramps, watery vaginal discharge, and lower back pain. Although lower back pain is present in normal pregnancy as well,...
-
Track & Monitor
Batteries in automotive: Mixed-metal oxide Li-ion battery
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the automotive industry’s Mixed-metal oxide Li-ion battery segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered...
-
Track & Monitor
Fuel cells in automotive: Fuel cell ion exchange membranes
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the automotive industry’s Fuel cell ion exchange membranes segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or...